Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in Eur J Cancer Retrieve available abstracts of 49 articles: HTML format Text format

Single Articles

January 2012
1. HUIDOBRO C , Urdinguio RG, Rodriguez RM, Mangas C, et al
   A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
   Eur J Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MEKENKAMP LJ , Heesterbeek KJ, Koopman M, Tol J, et al
   Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancer.
   Eur J Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KENNECKE H , Berry S, Wong R, Zhou C, et al
   Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.
   Eur J Cancer. 2012;48:37-45.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. KAWAMURA M , Toiyama Y, Tanaka K, Saigusa S, et al
   CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. KORNMANN M , Hebart H, Danenberg K, Goeb R, et al
   Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: Results of a randomised multicentre trial.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KHATTAK MA , Townsend AR, Beeke C, Karapetis CS, et al
   Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HONG SP , Min BS, Kim TI, Cheon JH, et al
   The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. ERCOLANI G , Cucchetti A, Cescon M, Peri E, et al
   Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
   Eur J Cancer. 2011;47:2291-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
9. DE GRAMONT A
   Re-challenge and the concept of lines of therapy in metastatic colorectal cancer.
   Eur J Cancer. 2011;47 Suppl 3:S76-84.
   PubMed     Text format     Related articles   
   
   
   
   
10. VERHOE C , de Wilt JH, Burger JW, Verheu HM, et al
    Surgery of the primary in stage IV colorectal cancer with unresectable metastases.
    Eur J Cancer. 2011;47 Suppl 3:S61-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. STEIN A , Atanackovic D, Bokemeyer C
    Current standards and new trends in the primary treatment of colorectal cancer.
    Eur J Cancer. 2011;47 Suppl 3:S312-4.
    PubMed     Text format     Related articles   
    
    
    
    
12. VAN HAL G , Hoeck S, Van Roosbroeck S
    Screening for colorectal cancer: sense and sensibilities.
    Eur J Cancer. 2011;47 Suppl 3:S156-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. VAN DE VELDE CJ
    Chairperson's introduction: Survival of patients with metastatic colorectal cancer has dramatically improved over the last decade. .
    Eur J Cancer. 2011;47 Suppl 3:S50-1.
    PubMed     Text format     Related articles   
    
    
    
    
14. WIGGERS T
    Management of local recurrence of rectal cancer.
    Eur J Cancer. 2011;47 Suppl 3:S290-1.
    PubMed     Text format     Related articles   
    
    
    
    
15. ZHANG F , Meng F, Li H, Dong Y, et al
    Suppression of retinoid X receptor alpha and aberrant beta-catenin expression significantly associates with progression of colorectal carcinoma.
    Eur J Cancer. 2011;47:2060-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. WATANABE T , Kobunai T, Yamamoto Y, Matsuda K, et al
    Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways.
    Eur J Cancer. 2011;47:1946-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
17. KRAMER HU , Schottker B, Raum E, Brenner H, et al
    Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differences.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
18. XIANG HP , Geng XP, Ge WW, Li H, et al
    Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SIMKENS LH , Koopman M, Mol L, Veldhuis GJ, et al
    Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ELFERINK MA , Pukkala E, Klaase JM, Siesling S, et al
    Spatial variation in stage distribution in colorectal cancer in the Netherlands.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BOUCHAHDA M , Levi F, Adam R, Rougier P, et al
    Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ALFA-WALI M , Tait D, Allen-Mersh T, Tekkis P, et al
    Colorectal cancer in HIV positive individuals: The immunological effects of treatment.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. COHEN EE , Sharma MR, Janisch L, Llobrera M, et al
    A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
    Eur J Cancer. 2011;47:1484-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. MOLLER H , Sandin F, Robinson D, Bray F, et al
    Colorectal cancer survival in socioeconomic groups in England: Variation is mainly in the short term after diagnosis.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CLARKE SJ , Yip S, Brown C, van Hazel GA, et al
    Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LAMBREGTS DM , Maas M, Cappendijk VC, Prompers LM, et al
    Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SHITARA K , Ura T, Matsuo K, Takahari D, et al
    Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
28. BELT EJ , Fijneman RJ, van den Berg EG, Bril H, et al
    Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ADELSTEIN BA , Dobbins TA, Harris CA, Marschner IC, et al
    A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ZLOBEC I
    Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapy.
    Eur J Cancer. 2011;47:1125-6.
    PubMed     Text format     Related articles   
    
    
    
    
31. DHADDA AS , Dickinson P, Zaitoun AM, Gandhi N, et al
    Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.
    Eur J Cancer. 2011;47:1138-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
32. DRANITSARIS G , Truter I, Lubbe MS
    The development of a value based pricing index for new drugs in metastatic colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
33. THONG MS , Mols F, Lemmens VE, Creemers GJ, et al
    Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based study.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. XING J , Myers RE, He X, Qu F, et al
    GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SCARPA M , Bortolami M, Cecchetto A, Faggian D, et al
    Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis.
    Eur J Cancer. 2011;47:611-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
36. DEKKER N , van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, et al
    Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FABER C , Horst D, Hlubek F, Kirchner T, et al
    Overexpression of Dicer predicts poor survival in colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. RIBBA B , Watkin E, Tod M, Girard P, et al
    A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers.
    Eur J Cancer. 2011;47:479-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. OLSSON LI , Granstrom F, Glimelius B
    Socioeconomic inequalities in the use of radiotherapy for rectal cancer: a nationwide study.
    Eur J Cancer. 2011;47:347-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
40. MANDERS P , Spruijt L, Kets CM, Willems HW, et al
    Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SARGENT D , Shi Q, Yothers G, Van Cutsem E, et al
    Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. CASTRO FA , Forsti A, Buch S, Kalthoff H, et al
    TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. CAVALLI-BJORKMAN N , Lambe M, Eaker S, Sandin F, et al
    Differences according to educational level in the management and survival of colorectal cancer in Sweden.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. RODRIGUEZ J , Boni V, Hernandez A, Bitarte N, et al
    Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. KILIC N , Feldhaus S, Kilic E, Tennstedt P, et al
    Brachyury expression predicts poor prognosis at early stages of colorectal cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LUO XJ , Li LL, Deng QP, Yu XF, et al
    Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.
    Eur J Cancer. 2011;47:316-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZHANG W , Wang J, Zou B, Sardet C, et al
    Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1.
    Eur J Cancer. 2011;47:121-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
48. KHAN NF , Ward AM, Watson E, Rose PW, et al
    Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK.
    Eur J Cancer. 2010;46:3339-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. GUIMARAES AP , Rocha RM, da Cunha IW, Guimaraes GC, et al
    Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
    Eur J Cancer. 2010;46:3307-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: